Angiogenesis in Women With Angina Pectoris Who Are Not Candidates for Revascularization

PHASE3UnknownINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

November 30, 2009

Conditions
Angina Pectoris
Interventions
GENETIC

Ad5FGF-4

Adenovirus serotype-5 mediated human fibroblast growth factor-4 gene transfer

GENETIC

Placebo

Control group

Trial Locations (47)

10021

Lenox Hill Heart & Vascular Institute, New York

17011

Heritage Cardiology Associates, Camp Hill

17822

Geisinger Clinic, Danville

20010

Cardiovascular Research Institute, Washington D.C.

27710

Duke University Medical Center, Durham

30342

St Joseph's Research Institute, Atlanta

32610

University of Florida, Gainesville

32803

Florida Hospital, Orlando

35294

University of Alabama, Birmingham

37208

Meharry Medical College, Nashville

38138

The Stern Cardiovascular Center, Germantown

40205

Cardiovascular Associates, Louisville

44035

North Ohio Heart Center, Elyria

45219

The Lindner Clinical Trial Center, Cincinnati

46290

The Care Group, Indianapolis

46804

Northern Indiana Research Alliance, Fort Wayne

48073

William Beaumont Hospital, Royal Oak

48109

University of Michigan Medical Center, Ann Arbor

54401

Care Foundation, Wausau

55407

Minneapolis Heart Institute, Minneapolis

55805

St. Mary's Duluth Clinic, Duluth

60148

Midwest Heart Foundation, Lombard

60504

Fox Valley Cardiovascular Consultants, Aurora

63128

St. Anthony's Medical Center, St Louis

64111

Mid America Heart Institute, Kansas City

68131

Creighton University, Omaha

68506

BryanLGH Heart Institute, Lincoln

73109

Oklahoma Cardiovascular Associates, Oklahoma City

75226

Baylor University Medical Center at Dallas, Dallas

75701

Cardiovascular Associates of East Texas, Tyler

78229

South Texas Cardiovascular Consultants, San Antonio

80012

Aurora Denver Cardiology, Aurora

80120

South Denver Cardiology, Littleton

83712

St. Luke's Idaho Cardiology Associates, Boise

85206

Banner Heart Hospital, Phoenix

85715

Southwest Heart, Tucson

90048

Cedars-Sinai Medical Center, Los Angeles

90210

Access Clinical Trials, Beverly Hills

92103

UCSD Medical Center, San Diego

92691

Mission Internal Medical Group, Mission Viejo

97225

Providence Heart & Vascular Institute, Portland

98122

Swedish Medical Center, Seattle

04102

Maine Medical Center, Portland

02114

Massachusetts General Hospital, Boston

07450

The Valley Hospital, Ridgewood

02906

The Miriam Hospital, Providence

05401

Fletcher Allen Health Care, Burlington

Sponsors
All Listed Sponsors
lead

Cardium Therapeutics

INDUSTRY

NCT00438867 - Angiogenesis in Women With Angina Pectoris Who Are Not Candidates for Revascularization | Biotech Hunter | Biotech Hunter